1. Wang, J, Yang, J W, Zeevi, A, Hutchinson, I V, Burckart, G J. 2007. IMPDH1 gene polymorphisms and association with acute rejection in renal transplant patients. In Clinical pharmacology and therapeutics, 83, 711-7. doi:. https://pubmed.ncbi.nlm.nih.gov/17851563/
2. Sakti, Dhimas H, Cornish, Elisa E, Nash, Benjamin M, Jamieson, Robyn V, Grigg, John R. 2023. IMPDH1-associated autosomal dominant retinitis pigmentosa: natural history of novel variant Lys314Gln and a comprehensive literature search. In Ophthalmic genetics, 44, 437-455. doi:10.1080/13816810.2023.2215310. https://pubmed.ncbi.nlm.nih.gov/37259572/
3. Ruan, Hailong, Song, Zhengshuai, Cao, Qi, Zhang, Xiaoping, Chen, Ke. 2020. IMPDH1/YB-1 Positive Feedback Loop Assembles Cytoophidia and Represents a Therapeutic Target in Metastatic Tumors. In Molecular therapy : the journal of the American Society of Gene Therapy, 28, 1299-1313. doi:10.1016/j.ymthe.2020.03.001. https://pubmed.ncbi.nlm.nih.gov/32209435/
4. Bowne, Sara J, Liu, Qin, Sullivan, Lori S, Pierce, Eric A, Daiger, Stephen P. . Why do mutations in the ubiquitously expressed housekeeping gene IMPDH1 cause retina-specific photoreceptor degeneration? In Investigative ophthalmology & visual science, 47, 3754-65. doi:. https://pubmed.ncbi.nlm.nih.gov/16936083/
5. Kagaya, Hideaki, Miura, Masatomo, Saito, Mitsuru, Habuchi, Tomonori, Satoh, Shigeru. 2010. Correlation of IMPDH1 gene polymorphisms with subclinical acute rejection and mycophenolic acid exposure parameters on day 28 after renal transplantation. In Basic & clinical pharmacology & toxicology, 107, 631-6. doi:10.1111/j.1742-7843.2010.00542.x. https://pubmed.ncbi.nlm.nih.gov/20136638/
6. Liu, Chengdong, Zhang, Wanli, Zhou, Xiaohan, Liu, Li. 2022. IMPDH1, a prognostic biomarker and immunotherapy target that correlates with tumor immune microenvironment in pan-cancer and hepatocellular carcinoma. In Frontiers in immunology, 13, 983490. doi:10.3389/fimmu.2022.983490. https://pubmed.ncbi.nlm.nih.gov/36618420/
智鼠故事 
